A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
MacroGenics
MacroGenics
Xencor, Inc.
Eli Lilly and Company
Canadian Cancer Trials Group
Xencor, Inc.
MacroGenics
Gilead Sciences
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Swiss Cancer Institute
Pfizer
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
University of Southern California
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Barbara Ann Karmanos Cancer Institute
University of Arizona
City of Hope Medical Center
Valerio Therapeutics
National Cancer Institute (NCI)
Indiana University
University of Minnesota
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center